chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I developed Shingles in my chest and back on the right side of my body.; This is a spontaneous report from a contactable consumer, the Patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 06Apr2021 at 16:30(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and diabetes. The patient did not take any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 06Mar2021 at 11:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation and Ciprofloxacin on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 the patient developed Shingles in his chest and back on the right side of his body. The events  resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles and included treatment with valacyclovir. The clinical outcome of the event Shingles in his chest and back on the right side of his body was recovering.   No follow-up attempts are needed. No further information is expected.
Redness and swelling noted ab 27-28 hours after vaccination. Diameter 1.5", increasing Dtap L arm - upper, PCV 7 R arm - lower on 06-22-07 to about 2" resolved on 06-24-07, mild tenderness no fever.
Beginning on May 29, 2021, symptoms began with persistent headache and numbness in legs and feet.  By June 2, 2021, severe pain in legs, arms, abdomen with throbbing headache, barely able to stand up or walk.  Went to emergency room evening of June 2, 2021, but was released with suspected viral infection and was told symptoms should subside.  Symptoms got worse, with the addition of full facial paralysis and revisited same emergency room on June 6, 2021.  Admitted to hospital and diagnosed with Guillian-Barre Syndrome.  Spent six days in hospital receiving IGIV treatment over five nights.  Released on June 12, 2021 with severe upper body weakness, limited leg weakness, constant headaches, Bell's palsy and deteriorated vision.  After two weeks of recovery, including doctor's visits and physical therapy, still weakness in limbs and Bell's palsy with deteriorated vision.
After 3 years of remission of my Ulcerative Colitis, I am active again....I am wondering if this is because of the vaccine over-activating my immune system.   I get my 2bd vaccine on March 12
Pt. received Moderna vaccine as an inpatient in the hospital. She is 14 years old and when discharged she could not obtain a second vaccine due to being under 18
One week after vaccine I developed a rash which started on both upper arms and then developed on my chest. No new products, supplements, no travel to explain the rash. I am not prone to skin rashes.
autoimmune disease p-anca vasculitis Pulmonary Embolisms Appendicitis Kidney Disease Blood/protein in urine
10/12/20 arm a little sore and late afternoon one shooting pain down arm then gone.  I was very sick from midnight on. I woke up with a very bad headache and my jaw was extremely painful like everything had swelled. I was very dizzy and disoriented and had to hold onto cabinets getting to the bathroom to remove my MAD sleep appliance & put on my jaw aligner. Had chills all night, fever and headache.  I took Advil- one of the meds advised for side effects on the list given me and it reduced fever.  Later temp went to 99 and I took advil again. No sleep at all. Temp went down, but in the morning 8am-10am I still had chills, headache and temp started to go up to 100.7.  I took more Advil, temp went to normal.  By afternoon I was okay, but tired. Everything cleared up by late afternoon around 5:00pm.
rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced RASH (rash). At the time of the report, RASH (rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Blood pressure medications  Treatment information included Steroids.
muscle pain throughout body; headache; mild nausea; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 25Mar2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included post herpetic neuralgia and hypothyroidism. The patient had allergies to sulfa drugs. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 19:15, the patient experienced headache, mild nausea, muscle pain throughout body and tiredness. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the adverse events. The clinical outcomes of the events headache, mild nausea, muscle pain throughout body and tiredness were recovered on an unknown date in Mar2021.    No follow-up attempts are needed; information about lot number cannot be obtained.
This spontaneous report was received from a nurse concerning multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA as prophylaxis (Strength, dose, route, lot # and expiration date were not reported), which experienced a temperature excursion of 22 Fahrenheit degrees for an unspecified timeframe. It was unknown if there were previous temperature excursions. Data logger was not involved. No adverse effects were reported. A product quality complaint was not involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1706USA007466: US-009507513-1707USA000721: US-009507513-1707USA000723: US-009507513-1707USA000724.
Patient had just received the Pfizer vaccine. I called patient back for lab draw when he complained of feeling like he was going to vomit. He was wobbly upon standing. We helped patient into bathroom as he still said he needed to vomit. Patient sat down on toilet and rested until he didn't feel nauseated. Patient stated he was ready to have his blood drawn. As we got him seated in the draw chair, The RN came back in. I explained that the patient became ill from the vaccine after she had left. She asked if he felt better now, he said yes and that was all that was stated/done.
nerve pain in her side/pains are ongoing; This case was reported by a consumer via call center representative and described the occurrence of nerve pain in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (shingles virus on her stomach side and back). Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   In March 2018, the patient received the 2nd dose of Shingrix. On an unknown date, 1 year after receiving Shingrix, the patient experienced nerve pain. On an unknown date, the outcome of the nerve pain was not recovered/not resolved.   It was unknown if the reporter considered the nerve pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 25-OCT-2022 Reporter's Comment: Reported stated that about 4 years ago patient had shingles virus on her stomach/side, and back. After it cleared patient got the Shingrix series. The patient believed the doses were administered in January and March about 4 years ago.  The patient started having nerve pain in her side where the shingles rash was years prior. The pains were ongoing. The patient does not have the exact dates of administration or lot number expiration date information. Reporter consented to follow up.
No adverse event. Patient received Pfizer Covid19 vaccine (dose1) 4/24/2021 and previously received Moderna Covid 19 vaccine (dose 1) on 03/28/2021. Previous immunization was not reported by the patient but was discovered after administration of the Pfizer vaccine upon search on registry.
Patient states that her arm has been numb since she received vaccine. She has not sought medical attention regarding this issue. When I spoke to her on 01/04/21 I instructed her to reach out to a medical doctor in order to have her symptoms looked at.
My son legs bruised. His legs and arms had several bruises the size of a quarter. He had petichiae all over his body, His platelets drop. And continue dropping still.
all started 7am 11/30/2021 nausea, hot flashes, sweating, dizziness, headache, fatigue, brain fog
Pt. became diaphoretic and had a syncopal episode. Pt. was caught by staff and lowered to the ground. Pt. was assessed by EMS and stated to them that he "always passes out when he get a shot." Pt. refused transport or treatment. Pt. left the vaccination site under his own power.
At the 36 hour mark clavicle lymph node swelled to a gum ball size, palpable and extremely painful. As of this claim, still large and pain had reduced by 25%
Patient was given MENACTRA and TRUMENBA at age 16, developed meningitis like sx. Received 2nd dose of TRUMENBA yesterday (7-18-17) experience same sx-with headache, body ache, nausea and vomiting.
pt recv vax & rt leg tenderness & constant crying for 24hr;taken to MD poss rxn to immun;
SYNCOPE OCCURED MORE THAN 5 MINUTES AFTER ADMINISTRATION WHILE PATIENT WAS WALKING, SPONTANEOUSLY RESOLVED QUICKLY. PATIENT WAS SWEATING PROFUSELY AND HAD GOOSEBUMPS, LOW PULSE RATE AT INITIAL EXAM . PATIENT FELL AND STRUCK BACK OF HEAD ON FLOOR SO EXTRA PRECAUTIONS TAKEN BEFORE RELEASING PATIENT. EMS RESPONDED AND EXAMINED PATIENT WHO WAS ABLE TO LEAVE FACILITY ON HIS OWN.
Neck started getting really tight, arm of injection became extremely painful, had diarrhea and headache.  Fever of 102.3.  Arm swelled and hurt from elbow to neck base. Headache has continued from 10PM last night to now.
26JUN95 itchy eyes, weak, tightness in throat, runny nose; visited primary MD 27JUN95 & recvd inj Aristocrat; inject site on 30JUN95 still edematous & red;
Initial unsolicited report received from a nurse on 02 July 2015. A 20-year-old male patient, had received a second dose of MENACTRA (batch number U4846BA, expiry date 01 March 2016) intramuscularly in left deltoid on 29 June 2015 (16:50 hours). Patient had no other vaccine within four weeks of vaccinations. It was also reported that, patient had no illness at the time of vaccination and pre-existing physician allergies, birth defect, medical conditions. On 30 Jun 2015, i.e. after twelve hour forty minutes post vaccination patient felt light headed and it got worse during day and was sick to stomach. On 01 July 2015, i.e. two days after vaccination patient experienced some swelling at left site. Patient had no laboratory investigations. The patient had too ADVIL for lightheadedness. At the time of this report, outcome of event was unknown. Documents held by sender: none. Follow up information received from a health care professional on 22 July 2015. It was reported that on an unspecified date the patient was completely recovered and no corrective treatments were given to patient. Documents held by sender: none.
15 YEAR OLD PROVIDED WITH PFIZER VACCINE 5-11 YEAR OLD FORMULATION.
Pt presented today for Pfizer booster 3rd dose. She had first Pfizer shot on 3/13/2021 and 2nd Pfizer dose on 4/3/2021. Moderna Booster #3 administered instead, I became aware of the situation and I was able to communicate with the patient while waiting for her 15 minutes observation time. I answered all her concerns and had no further questions. Patient went home in stable condition.
While asleep, Mon, 03-15-21, woken by severe shills, shaking, and tremors of the arms and hands. While asleep, Wed, 03-17-2021, woken again by severe shills, shaking, and tremors of the arms and hands. Thursday, 03-18-2021, rising from a chair I was suddenly stricken by severe pain and weakness in my lower back, hip, groin, and thigh, at about 10:00 PM.
At site of MMR vaccine, got scattered papular erythematous rash approximately 20 in total approximately 5cm in diameter around spot band aid. Happened about 5 minutes after vaccine administration. When evaluated about 10 minutes after vaccine given, noted to have five on right cheek. Resolved after 10-15 minutes. Resolved later in day.
Post menopausal woman. Period began again day after shot. 4 weeks later heavy period with bleeding soaking pads every hour with thick clots.   Also experienced allergic reaction at time of injection. Swelling of lips and difficulty breathing. Took Benedryl.
experienced reactogenicity of leg pain in both calves during exercise when walking; This is a spontaneous report from a contactable other hcp (Patient). A 44-years-old non-pregnant female patient received third (booster) dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: not reported), via an unspecified route of administration, administered in Arm Left on 30Sep2021 17:00 (at the age of 44 years), as a single dose for COVID-19 immunization. The patient medical history and concomitant medications was not reported. Previously patient received second dose of BNT162B2 vaccine (Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 26Feb2021 (at the age of 43 years), as single dose and first dose of BNT162B2 vaccine (Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 05Feb2021 (at the age of 43 years), as single dose for COVID-19 immunization and after first set of vaccines had reactogenicity of leg pain in both calves during exercise when walking past 7 days. Known allergies not reported. No other vaccine received in four weeks. No COVID prior vaccination. Not COVID tested post vaccination. On 30Sep2021, the patient experienced reactogenicity of leg pain in both calves during exercise when walking. Patient stated, after first set of vaccines had reactogenicity of leg pain in both calves during exercise when walking past 7 days (last over 30days and slowly disappeared. received 3rd injection on 30sep2021 and same issue appeared when walking during exercise. No treatment was received. The clinical outcome of the event was not recovered.  Follow-up (26Oct2021): This is a follow-up spontaneous report from a contactable other-HCP. This other-HCP reported in response to HCP letter sent via telephonic follow-up activity.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow
Immediate reaction at site of injection of flu shot in Lt. deltoid. Redness and itching.
Tiredness; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8727), via an unspecified route of administration on 24Mar2021 12:18 as 1st dose, single for covid-19 immunization. Medical history included drug hypersensitivity. The patients concomitant medications were not reported. Patient had not administered any additional vaccine on the date of Pfizer vaccine. Patient family history was reported as none. On 24Mar2021, The patient experienced tiredness and headache. Patient received her second dose of BNT162B2 (Lot: EW0161) on 14APR2021. The events were recovered on 26Mar2021.  No follow-up attempts are needed. No further information is expected.
Pt recv vax on 2/12/99; on 2/13/99 pt exp whelps on back, abdomen & arms w/ itching; tx=Benadryl, Tylenol
Initial report received on 24 April 2009 from a health care professional. A 35-year-old female patient, who had a concurrent urinary tract infection, had received at the patient's request since she works with children, a first intramuscular left deltoid injection of ADACEL (lot number C3098BA) on 20 April 2009 at 16:58 pm. The afternoon after receiving the ADACEL injection, the area was red, swollen, sore and had a "knot." Two days later, the patient was seen in the physician's office for several days of sudden onset of severe arm pain that was episodic and constant. Physical examination revealed left upper extremity with erythema approximately 7cm in size. The patient was diagnosed with cellulitis and given LEVAQUIN. She was also prescribed LORTAB 5 the same day. Two days later, the patient returned to the physician's office and the area was larger and more reddened. A CBC (complete blood count) was completed that revealed 50.8% lymphocytes (normal range 20.0-50.0%). The rest of the CBC was unremarkable. The redness and edema did resolve after antibiotic treatment, and the pain was improving by day four. At the time of this report, the recovery status of the patient was unknown. Documents held by sender: Physician notes, laboratory results.
Case number PHEH2016US010685 is initial spontaneous report received from other healthcare professional on 27 Apr 2016. This report refers to patient of unknown age and gender. Medical history and current condition were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515101) intramuscularly at a dose of 0.5 ml on an unknown date. It was reported that, unknown number of FLUVIRIN vaccinations were given following multiple temperature excursions below 36 degrees Fahrenheit and excursions 30 degrees for greater than 24 hours and 26 degrees Fahrenheit for 12 hours. No adverse event was reported following this medication error. This case was considered as lost to follow up as there was no consent to contact with reporter.
Client in advertently given KINRIX for 4th DTAP and 4th POLIO.
Vaccine administered after 7 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 7 days of puncturing the vial) in a 25-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 7 days of puncturing the vial). On 03-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 7 days of puncturing the vial) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided bythe reporter. No treatment information provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim.
Sore arm; This is a spontaneous report received from a non-contactable consumer, the patient. A 40-years-old age female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 16Mar2021 at 02:00 PM (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient had no symptoms associated with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had no allergies to food, medication or other products. On 16Mar2021 at 03:00 PM, the patient experienced swelling sore arm. Therapeutic measures were not taken as a result of event. The clinical outcome for the sore arm was recovering at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I came down with COVID-19 on 03/19/2022: Extreme fatigue, body chills, body aches, nausea, night sweats. I was having hallucinations. I also had a cough that had become very bad. I felt like my chest was having a battle in it. I went to the clinic, the week I had COVID-19 and I had a monoclonal antibody treatment. I began to feel better almost immediately however the Monday after, I began to have symptoms occur again. I become very nauseous and night sweats and I am still suffering from fatigue. I have also been ice cold since having COVID-19. My psychiatrist told me that I am also having multiple issues come about from stress as well. I am having diverticulitis and diverticulosis issues as well. I am taking the Diazepam to help with my symptoms as well. My doctor stated that they may have to remove a portion of my colon as well if pain persists. I have also been having Diarrhea as well that has been causing issues as well. I have also been experiencing extreme brain fog that has been going on since contracting COVID-19.
Patient received her Covid 19 Janssen vaccine at approximately 7:00am.  At approximately 8:00am she started experiencing itching in her eyes. As time went on she stated she started to experience itching all over her body and a tickle in throat.  She called her doctor and they advised her to take benadryl to manage the adverse reaction.
Narrative:  91 yo male died on 5/2021 at hospital. No information in records about pt's death. Pt had received covid vaccinations on 1/12/21 and 2/9/21. Likely death is not related to vaccines given pt's advanced age and length of time btwn date of death and vaccines.
Patient presented on 10/16/2003 with fever 100.8, decreased appetite, rash, sore throat = 100.  Eyes: clear (unable to read); Skin: scattered papular lesions on abdomen, left extremity, buttocks, back, face.
He stated that he had a positive COVID contact and personally feels mildly short of breath and felt warm at home.  He also feels that he has a mildly productive cough and denies any history of bronchitis
Noticed a severe uptick in my hidendrinitis. Lot more bloody discharge, growth in infected areas.
sleepiness day after vaccine and also on day 2.; Extreme fatigue; This is a spontaneous report from a contactable consumer (patient). A 56-year-old non-pregnant female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/ Lot number and expiry date were not reported) via an unspecified route of administration in right arm on 06Feb2021 14:30 as single dose for COVID-19 immunisation. Patient had no medical history. The patient did not have any known allergies. Patient did not receive other vaccine in four weeks of vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), sertraline hydrochloride (ZOLOFT) and omeprazole magnesium (PRILOSEC) (other medications in two weeks of vaccination. Patient did not have COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. On 07Feb2021 at 24:00, patient experienced extreme fatigue and sleepiness day after vaccine and also on day 2. No treatment was received. On an unknown date, the outcome of event was resolved.
Experienced a hot, burning sensation in right arm for 2-3 days. Also, had a very bad migraine.